NEUROGEN CORP - FORM 8-K - EX-3.1 - BY-LAWS AMENDMENT - December 24, 2009

Attached files

file filename
8-K - FORM 8-K - NEUROGEN CORPd8k.htm
EX-2.1 - CERTIFICATE OF MERGER - NEUROGEN CORPdex21.htm
EX-10.4 - REAL ESTATE CONTINGENT VALUE RIGHTS AGREEMENT - NEUROGEN CORPdex104.htm
EX-10.2 - H3 CONTINGENT VALUE RIGHTS AGREEMENT - NEUROGEN CORPdex102.htm
EX-10.1 - APLINDORE CONTINGENT VALUE RIGHTS AGREEMENT - NEUROGEN CORPdex101.htm
EX-10.3 - MERCK CONTINGENT VALUE RIGHTS AGREEMENT - NEUROGEN CORPdex103.htm
EX-3.1 3 dex31.htm BY-LAWS AMENDMENT By-Laws Amendment

Exhibit 3.1

On December 23, 2009, Section 2.1 of the By-Laws of Neurogen Corporation was amended to read in full as follows:

“The number of directors which constitutes the whole Board of Directors shall be three.”